AMRS Stock Recent News

Amyris, Inc. (NASDAQ:AMRS ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Rachel Vatnsdal - JPMorgan Korinne Wolfmeyer - Piper Sandler Steven Mah - Cowen and Company Dan Rizzo - Jefferies Rick Schottenfeld - Schottenfeld Opportunities Fund Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris' Third Quarter 2022 Financial Results Conference Call. This call is being webcast live on the Events page of the Investors section of the Amyris website at amyris.com.

"Fit To Win," high ROI Capex and innovative marketing are reducing cash burn equaling 19% of H2 2022 and 26% of 2023 product sales, delivering positive cash flow in 2023. Barra Bonita changes everything.  Mfg. efficiencies and 30-60% lower COGS swings Amyris Ingredients margins from negative to positive 20-50%, producing faster and more profitable Ingredient growth than we expected.

Supply chain problems appear to have caused elevated COGS and shipping and handling expenses, a problem faced by many beauty brands and DTC companies. Insourcing production and changing packaging will resolve some of these issues and help improve profitability.

A new loan facility caused some consternation.

Amyris' more frequent and larger "exclusivity" deals introduce a unique, recurring catalyst to its business model that enhances profitability and requires raising our earnings estimates. We're raising our EPS estimates from ($1.19) to ($0.22)/share for 2022, from ($0.36) to ($0.09)/share for 2023, from $0.08 to $0.35/share for 2024 and from $0.62 to $0.88/share for 2025.

Synthetic biology maker Amyris owns a 60% global market share for a product that's increasingly used in personal care products. Will it notch a profit in 2024?

Amyris, Inc. (NASDAQ:AMRS ) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President & Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Conference Call Participants Colin Rusch - Oppenheimer Steven Mah - Cowen & Co. Sameer Joshi - H.C. Wainwright Rachel Vatnsdal - JPMorgan Randy Baron - Pinnacle Graham Tanaka - Tanaka Capital Management Operator Welcome to the Amyris Second Quarter 2022 Financial Results Conference Call.

Amyris' disruptive vertically-integrated business model should deliver favorable results beginning in H2 2022, linking synthetic biology, clean chemistry, precision fermentation, scaling, & hero ingredients with consumers, partners, & retailers. After spending $2+ billion over 15+ years developing revolutionary science, Q3 startups of a next-generation fermentation facility and finishing plants should significantly boost Amyris profitability for Ingredients and Consumer Products.

There are high hopes that Amyris' Barra Bonita plant will rein in costs and improve the company's profitability. Fermentation is just one cost component though, meaning Barra Bonita will only have a limited impact, particularly on the consumer business.

Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.